Embla Medical hf. (LON:0FIW)

Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of GBP 1.58 billion. The enterprise value is 1.93 billion.

Market Cap	1.58B
Enterprise Value	1.93B

Important Dates

The next estimated earnings date is Tuesday, October 21, 2025.

Earnings Date	Oct 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	425.59M
Shares Outstanding	n/a
Shares Change (YoY)	-0.80%
Shares Change (QoQ)	-3.69%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	160.01M

Valuation Ratios

The trailing PE ratio is 29.55 and the forward PE ratio is 23.24.

PE Ratio	29.55
Forward PE	23.24
PS Ratio	2.47
PB Ratio	2.59
P/TBV Ratio	n/a
P/FCF Ratio	21.94
P/OCF Ratio	18.08
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.90, with an EV/FCF ratio of 26.84.

EV / Earnings	36.14
EV / Sales	2.98
EV / EBITDA	14.90
EV / EBIT	20.58
EV / FCF	26.84

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.68.

Current Ratio	1.79
Quick Ratio	0.95
Debt / Equity	0.68
Debt / EBITDA	3.35
Debt / FCF	5.74
Interest Coverage	5.72

Financial Efficiency

Return on equity (ROE) is 9.27% and return on invested capital (ROIC) is 5.58%.

Return on Equity (ROE)	9.27%
Return on Assets (ROA)	4.66%
Return on Invested Capital (ROIC)	5.58%
Return on Capital Employed (ROCE)	8.47%
Revenue Per Employee	159,394
Profits Per Employee	13,346
Employee Count	4,061
Asset Turnover	0.54
Inventory Turnover	2.15

Taxes

In the past 12 months, Embla Medical has paid 16.51 million in taxes.

Income Tax	16.51M
Effective Tax Rate	23.48%

Stock Price Statistics

The stock price has increased by +13.21% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+13.21%
50-Day Moving Average	32.02
200-Day Moving Average	37.13
Relative Strength Index (RSI)	49.37
Average Volume (20 Days)	12,139

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of GBP 637.58 million and earned 53.38 million in profits. Earnings per share was 0.13.

Revenue	637.58M
Gross Profit	399.97M
Operating Income	88.04M
Pretax Income	70.33M
Net Income	53.38M
EBITDA	103.46M
EBIT	88.04M
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 68.70 million in cash and 412.90 million in debt, giving a net cash position of -344.20 million.

Cash & Cash Equivalents	68.70M
Total Debt	412.90M
Net Cash	-344.20M
Net Cash Per Share	n/a
Equity (Book Value)	610.14M
Book Value Per Share	1.42
Working Capital	145.03M

Cash Flow

In the last 12 months, operating cash flow was 87.26 million and capital expenditures -15.37 million, giving a free cash flow of 71.89 million.

Operating Cash Flow	87.26M
Capital Expenditures	-15.37M
Free Cash Flow	71.89M
FCF Per Share	n/a

Margins

Gross margin is 62.73%, with operating and profit margins of 13.81% and 8.37%.

Gross Margin	62.73%
Operating Margin	13.81%
Pretax Margin	11.03%
Profit Margin	8.37%
EBITDA Margin	16.23%
EBIT Margin	13.81%
FCF Margin	11.28%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.80%
Shareholder Yield	n/a
Earnings Yield	3.38%
FCF Yield	4.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 2.99 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	6